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Abstract: 2-Furonitrile is an interesting nitrile product for the chemical industry due to its use as
intermediate in the field of fine chemicals and pharmaceuticals or as a potential sweetener, as well
as due to its access from biorenewables. As an alternative to current processes based on, e.g., the
ammoxidation of furfural with ammonia as a gas phase reaction running at > 400 ◦C, we recently
reported an enzymatic dehydration of 2-furfuryl aldoxime being obtained easily from furfural and
hydroxylamine. However, improving the catalytic properties of the aldoxime dehydratase biocatalyst
from Rhodococcus sp. YH3-3 (OxdYH3-3) in terms of activity and stability remained a challenge. In this
contribution, the successful development of aldoxime dehydratase OxdYH3-3 mutants that were
generated by directed evolution and its enhanced activity toward 2-furfuryl aldoxime is reported.
The mutant OxdYH3-3 N266S showed an improved activity of up to six times higher than the wild
type when utilizing a substrate concentration of 50–100 mM of 2-furfuryl aldoxime.
Keywords: Aldoxime dehydratase; directed evolution; high-throughput screening; 2-furfuryl
aldoxime; 2-furonitrile
1. Introduction
The tasks for realizing access to industrial chemicals from biorenewables on scale include the
development of approaches for aromatic compounds as well as for nitriles starting from bio-based
raw materials and ideally waste-materials [1]. 2-Furonitrile, being known as intermediate in the
field of fine chemicals and pharmaceuticals or as a potential sweetener (due to an about thirty-fold
higher sweetening power compared to sucrose) [2], combines these two compound classes. As for
aromatic compounds within a bio-based economy, the furan moiety is regarded to be of particular
importance because this heteroaromatic framework can be directly constructed in a substituted
form from readily available sugars such as pentoses and hexoses, thus leading to 2-furfural and
5-hydroxymethylfurfural as the most prominent representatives [3]. The availability of 2-furfural from
natural waste sources makes its utilization attractive for the synthesis of derivatives with industrial
potential [1,3]. For example, furfural is obtained by an acid-catalyzed dehydration of cellulose
biomass, and its derivatives containing nitrogen atoms have interesting features, such as the ability of
furfurylamine to be used in the pharmaceutical synthesis or resin industry [4–7].
However, the current synthetic approaches for 2-furonitrile are limited. For example, the
preparation of 2-furonitrile from furfural through ammoxidation requires reaction temperatures
exceeding 400 ◦C [2], whereas other procedures that are conducted on lab scale revealed to be
tedious [8–12].
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In continuation of our research on the biocatalytic synthesis of nitriles under cyanide-free
conditions as an alternative synthetic technology for nitriles [13–25], we could also demonstrate a
proof of concept for the two-step conversion of furfural into 2-furonitrile (Scheme 1) [24,25]. In detail,
furfural (1) is transformed into its aldoxime (2) by spontaneous condensation with hydroxylamine,
which is a bulk chemical that is utilized in α-caprolactam manufacturing. Subsequently, the aldoxime
is enzymatically dehydrated in an aqueous medium to furnish the desired 2-furonitrile (3).
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Scheme 1. Two step synthesis of 2-furonitrile from furfural based on dehydration via aldoxime 
dehydrate OxdYH3-3. 
However, in spite of the availability of a recombinant form of an aldoxime dehydratase from 
Rhodococcus sp. YH3-3 (OxdYH3-3) [25], which was identified as a suitable biocatalyst for aromatic 
aldoximes in general and 2-furonitrile in particular, the limited enzyme activity and substrate 
concentration raise the demand for more active and stable biocatalysts as well as for a process 
running at elevated substrate loading. In the following, we report our results on the development of 
improved mutants of this enzyme that show an increased activity and enable an improved synthetic 
access to 2-furonitrile. 
2. Results and Discussion 
2.1. High throughput screening of OxdYH3-3 mutants by using a UV microspectrometer 
The generation of the OxdYH3-3 mutants for our study was carried out by error-prone PCR, and 
its potentially enhanced activity toward the target substrate 2-furfuryl aldoxime at a substrate 
concentration of 10 mM was screened with microplate spectroscopy. Since under UV light, 2-furfuryl 
aldoxime and 2-furonitrile showed maximum absorbance at 270 and 230 nm, respectively, the 
screening of the OxdYH3-3 mutants was based on measuring a decrease in absorbance at 270 nm. 
The clones that showed an absorbance between 0 and 1 (lower 10%) at 270 nm (Figure 1) were chosen 
for further studies.  
Accordingly, the OxdYH3-3 variants N266S, A224T, and P7H4 (Val264Ala, Ile302Ser, 
Gln330Leu) were prioritized, followed by sequence analysis (Figure 1).  
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to 2-furonitrile.
2. Results and Discussion
2.1. High Throughput Screening of OxdYH3-3 Mutants by Using a UV Microspectrometer
The generation of the OxdYH3-3 mutants for our study was carried out by error-prone PCR,
and its potentially enhanced activity toward the target substrate 2-furfuryl aldoxime at a substrate
concentration of 10 mM was screened with microplate spectroscopy. Since under UV light, 2-furfuryl
aldoxime and 2-furonitrile showed maximum absorbance at 270 and 230 nm, respectively, the screening
of the OxdYH3-3 mutants was based on measuring a decrease in absorbance at 270 nm. The clones that
showed an absorbance between 0 and 1 (lower 10%) at 270 nm (Figure 1) were chosen for further studies.
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Figure 1. The UV absorbance spectrum of OxdYH3-3 mutants. OxdYH3-3 mutant clones were
inoculated in 96 deep well plates, and fully-grown cells were transferred to new 96 well plates to
screen OxdYH3-3 mutants that showed an improving activity to 2-furfuryl aldoxime. 10 mM furfuryl
aldoxime was added in the plate, and, after a specific time, the reaction mixture was isolated and
diluted. The UV absorbance between 230 and 300 nm was measured. Among 10 microplates, N266S
was found in plate 6 (A), P7H4 and A224T were found in plate 7 (B).
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Accordingly, the OxdYH3-3 variants N266S, A224T, and P7H4 (Val264Ala, Ile302Ser, Gln330Leu)
were prioritized, followed by sequence analysis (Figure 1).
Subsequently, the overexpression level of OxdYH3-3 wild type (WT) and mutant proteins were
analyzed through SDS-PAGE. Thick bands at 41.3 kDa were observed, showing approximately the
same high overexpression level with OxdYH3-3 WT and mutants (Figure 2).
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2.2. The Improved Activity Measurement of OxdYH3-3 Mutants
In the next steps, we gained interest in evaluating the activity of selected mutants in synthetic
biotransformations. As in our previous work, the substrate concentration with the wild-type enzyme
was only 10 mM [25]. We studied these mutants in the dehydration of furfuryl aldoxime at increased 50
and 100 mM concentrations in the presence of a biocatalyst loading of approximately 0.5 g·L−1 wet cells
(Table 1). At first, E-3-pyridine aldoxime was used as a standard substrate since OxdYH3-3 showed
the highest relative activity for E-3-pyridine aldoxime in a previous study [24,25]. At an increased
substrate concentration of 100 mM of E-3-pyridine aldoxime, OxdYH3-3 N266S showed a three times
higher activity (1.73 U·g−1; measured according to the conversion after 1 h) compared to the one of the
wild-type enzyme (0.52 U·g−1; Table 1). In addition, this mutant N266S showed excellent activity for
2-furfuryl aldoxime at 100 mM with 1.16 U·g−1, which was four times higher than the one of the Oxd
YH3-3 WT. In comparison, the mutants OxdYH3-3 A224T and P7H4 appeared to have similar or just
slightly higher conversions compared to the wild-type enzyme (Table 1).
In terms of conversions, 19% and 5% were found for the wild-type of the aldoxime dehydratase,
OxdYH3-3 WT, when starting from a substrate concentration of 50 mM of E-3-pyridine aldoxime and
2-furfuryl aldoxime, respectively (Figure 3).
It is noteworthy that also in these biotransformations the mutant OxdYH3-3 N266S turned out to
be superior over the wild-type enzyme and gave a three times (54%) and eight times (40%) higher
conversion when comparing the data for the reactions running at 50 mM of E-3-pyridine and 2-furfuryl
aldoxime after a reaction time of 1 h, respectively (Figure 3).
Furthermore, the conversion could be further increased by simply adding more amount of
biocatalyst. For example, when the amount of catalyst was doubled, the conversion in the reaction
starting from 50 mM of 2-furfuryl aldoxime was 61% when using the whole cells containing the
wild-type enzyme OxdYH3-3 WT after a reaction time of 1 h. An even better result at such an increased
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biocatalyst loading was obtained in the presence of the mutant OxdYH3-3 N266S, which led to a full
conversion under such conditions (data not shown graphically).
Table 1. The activity of OxdYH3-3 WT and mutants. The activities at 1 h toward 50 and 100 mM of
E-3-pyridine aldoxime and 2-furfuryl aldoxime were compared.
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U·g−1 (µmol·min−1·g−1)
OxdYH3-3
E-3-pyridine aldoxime 2-furfuryl aldoxime
50 mM 100 mM 50 mM 100 mM
WT 0.62 0.52 0.15 0.29
N266S 1.85 1.73 1.24 1.16
A224T 0.68 0.52 0.37 0.28
P7H4 0.81 0.78 0.53 0.38
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Figure 3. Biotransformations of OxdYH3-3 WT and mutants (1 h) at 50 mM (A) and 100 mM (B) of
substrate concentration.
In addition to the improved conversions found in this biotransformation study, OxdYH3-3 N266S
showed improved activity data compared to the WT enzyme. The Vmax values of OxdYH3-3 WT
and N266S were 0.14 and 0.41 U (µM·min−1), respectively. In addition, Km and kcat values were
70 µM and 0.37 min−1 for WT and 650 µM and 2 min−1 for N266S, respectively. Even though the Km
value of OxdYH3-3 N266S was much higher than the one for the WT, the catalytic efficiency of N266S
was approximately five times higher than WT. In addition, kinetic data of other Oxd enzymes were
determined in previous studies, and the Km values of OxdRG and OxdA towards aromatic aldoximes
such as pyridine-3-aldoxime and pyridine-2-aldoxime were 20 and 3.4 mM, respectively [13–23,26,27].
Compared to these results, the Km values of OxdYH3-3 WT and N266S were significantly lower
towards the aromatic aldoxime 2-furfuryl aldoxime. Furthermore, OxdRE as the enzyme with
the highest homology to OxdYH3-3 WT among the Oxd enzymes, showed a higher Km value for
cyclohexanecarboxaldehyde oxime (0.99 mM) than OxdYH3-3 [28].
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It should be further added that a good correlation between the conversion determined by GC,
and the change of absorbance was observed. The decrease of absorbance in the UV spectra at 245
and 270 nm was consistent with the decrease of E-3-pyridine and 2-furfuryl aldoxime, respectively,
as measured by GC (Figure 4).
Accordingly, the mutant OxdYH3-3 N266S showed a significantly stronger decrease of the
maximum absorbance of 3-pyridine aldoxime and 2-furfuryl aldoxime at 245 and 270 nm, respectively,
compared to the wild-type enzyme OxdYH3-3 WT (and other mutants), thus indicating improved
catalytic abilities.
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Figure 4. Absorbance scans of reaction solutions after 1 h of reaction time for reactions being
performed at a substrate concentration of 50 mM of E-3-pyridine aldoxime (A) and 2-furfuryl
aldoxime (B). Experiments with solutions of the substrates without biocatalysts were carried out
as control experiments.
Thus, this methodology for the determination of the enzymatic activities and conversion of the
biotransformation through measurement of the absorbance at 245 and 270 nm instead HPLC, GC
or thin layer chromatography represents a practical and easy-to-carry-out alternative to screen new
biocatalysts and mutants towards the dehydration of various aldoximes.
2.3. Homology Modelling of OxdYH WT and N266S
A further goal was to rationalize the improved activity of the enzyme mutants. Toward this
end, homology model structures of the wild-type enzyme OxdYH3-3 WT and the prioritized mutant
N266S were constructed based on the literature-known OxdRE crystal structure [16] (PDB No. 3A17_A;
co-crystalized with heme and butyl aldoxime) and a subsequent docking with E-2-furfuryl aldoxime
by using the Autodock4 software (Figure 5).
The docking results showed that the nitrogen of N–OH in 2-E-furfuryl aldoxime was facing Fe in
the heme group (2.7 Å). In addition, His320 and Ser219 in OxdYH3-3 WT and N266S formed hydrogen
bonds with the oxygen atom of the N–OH group of the 2-furfuryl aldoxime ligand. It is noteworthy
that the distances of the hydrogen bonding of wild type and N266S as well as the free binding energies
did not show a significant difference, which indicates that the mutation did not directly influence
the interaction between the substrate and its adjacent residues (see also Supplementary Materials,
Figure S3).
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Nonetheless, a residues network analysis between the wild type enzyme and the mutant that
used Ring2 and Cytoscape [29,30] could suggest that the long-range interaction at the remote site could
have changed structure flexibility, thus leading to the observed beneficial effects (see Supplementary
Materials, Figure S4).
3. Materials and Methods
3.1. Materials and Preparation of OxdYH3-3 Transformants
Chemicals including E-3-pyridine aldoxime, 3-cyanopyridine, 2-furaldehyde, and 2-furonitrile
were purchased from Sigma Aldrich (Germany). OxdYH3-3 WT in a pET28b vector was constructed
and transformed into BL21(DE3) Escherichia coli cell followed by methods in the previous study [25].
3.2. Synthesis of 2-Furfuryl Aldoxime
2-Furfuryl aldoxime was synthesized from 2-furaldehyde. Toward this end, 20 mL of water
containing 2-furaldehyde (120.72 mmol) was ixed with 144.86 mmol NH2OH·HCl. Sodium carbonate
(72.43 mmol) dissolved in 30 mL of water was ad ed dropwise. After overnight reaction, it was
extr cted by adding the am volume of ethyl acetate thre times. The organic solut on was washed
with w ter and dried by magn sium sulpha e. Yellow powder was obtained after evapor ting
t solvent ith a rotary evaporator. The 1H-NMR sp ctra and ESI mass spectra wer measured
(see Supplementary Materi ls).
3.3. Construction of Mutant Library by Error-Prone PCR
The mutant library was constructed by using a PCR random mutagenesis kit (GeneMorph II
Rando Mutagenesis Kit, Agilent) followed the manual provided by a manufacturer with modification.
The forward primer was a T7 promoter primer (5′-TAATACGACTCACTATAGGG-3′), and the reverse
primer was a T7 terminator primer (5′-GCTAGTTATTGCTCAGCGG-3′). To be specific, error-prone
PCR was performed in 50 µL of a reaction solution containing 100 ng of pET28b–OxdYH3-3 as a
template, 1 µL of titanium Taq polymerase, 640 µM of MgSO4, 40 µM of dGTP, 0.1 µM of of each primer,
1 µL dNTP mix, and 5 µL of a titanium PCR buffer. The PCR program consisted of 25 cycles of 94 ◦C
for 30 s, 45 ◦C for 1.5 min, and 68 ◦C for 1 min. The amplified DNA fragment was purified and cloned
into the NcoI and HindIII sites of the pET28b vector (Novagen) by using an in-fusion HD Cloning Kit
(Takara) to obtain pET28b–OxdYH3-3 for expression as a C-terminal His-tagged protein. The plasmid
pET28b–OxdYH3-3 was transformed into BL21(DE3) and spread on the LB plate containing antibiotics.
For mutant screening, colonies were inoculated to a 1 mL autoinduction medium in a 96 deep well
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plate and cultured for 18 h at 30 ◦C. Twenty microliters of cell suspension were transferred to a 96 deep
well plate containing fresh 980 µL of an autoinduction medium and cultivated for 20 h at 30 ◦C.
3.4. Screening of OxdYH3-3 WT and Mutants by of UV Spectrum Scan
OxdYH3-3 was overexpressed in an autoinduction medium containing 0.2% glucose, 0.5% lactose,
1.2% tryptone, 2.4% yeast extract, 0.5% glycerol, and phosphate (0.17 M KH2PO4 and 0.72 M K2HPO4),
and the cell was harvested by centrifugation at 4 ◦C, 4,000 rpm for 30 min after 20 h of shaking
incubation at 30 ◦C for 20 h. The cell pellet was washed by a 50 mM phosphate buffer (pH 7.0) and
resuspended in a 1 mL phosphate buffer. A 190 µL cell suspension was transferred to 96 well plates,
and 10 µL of substrates (200 mM dissolved in DMSO) were added. After 3 and 20 h incubation at 30 ◦C,
the reaction mixture was centrifuged at 10,000 rpm for 10 min to remove the cell pellet, and 5–10 µL
solutions were transferred to clean 96 well following a 10-20 fold-dilution with a phosphate buffer to
measure UV absorbance. The enhanced activity toward 2-furfuryl aldoxime of mutated OxdYH3-3
was screened by measuring UV absorbance (Biorad). The absorbance of 2-furfuryl aldoxime and
2-furonitrile were scanned from 230 to 350 nm to determine the specific wavelength that showed the
biggest difference between aldoxime and nitrile.
3.5. Analysis of the DNA Sequence of OxdYH3-3 Mutants
Selected mutants were subjected to DNA sequence analysis. The mutant clones transformed into
BL21(DE3) were spread on an LB-agar plate containing 50 µg·mL−1 kanamycin and incubated at 37 ◦C
for 20 h. The single colony was inoculated in 5 mL of an LB broth and cultured for overnight at 37 ◦C in
the shaking incubator at 150 rpm. The plasmid was isolated by using the plasmid isolated kit (Analytik
Jena), and nucleotide sequences were analyzed by ABI 3730XL sequencing machines with the modified
Sanger method (Eurofins Genomics, Germany).
3.6. Protein Purification
Histidine-tagged OxdYH3-3 WT and N266S were purified by using nickel resin affinity
chromatography. Ni-NTA agarose resin was purchased from Qiagen. The soluble fraction from
lysis was loaded on 1–3 mL of Ni-NTA resin and incubated for 15 min following washing with 100 mL
of a washing buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0) and elution with 10 mL
of an elution buffer (50 mM NaH2PO4, 300 mM NaCl, 500 mM imidazole, pH 8.0). The buffer was
changed to a sodium phosphate buffer (pH 7.0, 50 mM) after purification by using a PD-10 desalting
column (GE Healthcare), and it was kept in a 4 ◦C freezer.
3.7. Characterization of Purified OxdYH3-3 Catalyst
A reaction solution containing 2-furfuryl aldoxime was prepared through the dilution of a DMSO
stock solution (1 M) with a phosphate buffer (pH 7.0, 50 mM). Twenty microliters of purified enzyme
was added to 80 µL of a substrate solution in 96 well microplates. The decreases of absorbance at
270 nm were measured over time at 30 ◦C. The extinction coefficient was determined by mixing the
10 µL of a 0.01–100 mM stock solution with 990 µL of a phosphate buffer, and 20 µL of the mixture
was transferred again to measure UV absorbance. The regression curve was drawn with Excel, and
the extinction coefficient was calculated based on the Beer–Lambert equation. The calculated extinct
coefficient of 2-furfuryl aldoxime was 17.4 mM−1·cm−1. The Km was determined by Origin program
by using Michaelis–Menten equation. One unit is defined as µM·min−1 (see Supplementary Materials,
Figure S2).
3.8. Conversion of Aldoximes to Corresponding Nitriles by Using OxdYH3-3 WT and Mutants
The transformants were inoculated to 5 mL of a TB (terrific broth) medium containing 50 µg·mL−1
kanamycin. After overnight cultivation at 37 ◦C, the culture was re-inoculated to 50 mL of an
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autoinduction medium containing 0.2% glucose, 0.5% lactose, 1.2% tryptone, 2.4% yeast extract, 0.5%
glycerol, and phosphate (0.17 M KH2PO4 and 0.72 M K2HPO4) and kept at 30 ◦C up to 18 h with
shaking. The overexpressed cell was collected and washed with distilled water once. The pellet was
resuspended to 5 mL of a phosphate buffer (pH 7.0, 50 mM) and stored at 4 ◦C in a freezer until it
was used in the next experiment. The overexpression level was analyzed by the SDS-PAGE of the
whole cell.
A volume of 100 µL of 3-pyridine aldoxime and 2-furfuryl aldoxime (0.5 and 1 M in DMSO,
respectively) were added to a 900 µL cell suspension. The mixtures were incubated in a shaker at 30 ◦C
with 1000 rpm for 1 h, and a sample of 100 µL reaction mixture was taken to measure GC. A volume
of 20 µL of 1 M NaOH and 180 µL of ethyl acetate was added to the reaction solution to inactivate
the enzyme. The reaction mixture was centrifuged to isolate the organic phase, which was subjected
to GC measurement. At the same time, 100 µL of the reaction mixture was isolated and centrifuged.
The clear supernatant was diluted 20 times with a phosphate buffer (pH 7.0, 50 mM) and transferred to
a 96 microwell plate to measure spectrophotometry.
On the other hand, 9.15 g of OxdYH3-3 WT and 8.24 g of N266S of wet cells were resuspended in
a phosphate buffer (pH 7.0, 50 mM) to make 15 mL. A two-milliliter solution was taken to measure
activity by using the whole cell. An activity-using aldoxime was measured with the same procesure
as above.
3.9. Determination of Conversion from Aldoximes to Nitrile by GC
The conversion was determined by GC measurement (Shimadzu GC-2010 plus). GC conditions
were optimized to efficiently separate the products from the reactants in a Phenomenex ZB-5MSi
capillary column (30 m × 0.25 mm × 0.25 µm). Nitrogen was used as carrier gas at a flow rate of
2.25 mL min−1 with an average velocity of 46.9 cm s−1 and a pressure of 147.6 kPa. The analysis run
was started with an oven temperature of 60 ◦C that ramped to 250 ◦C at 15 ◦C min−1.
3.10. Measurement of the UV Spectrum of Aldoximes and Nitriles After the Reaction
The enhanced activity toward 3-E-pyridine aldoxime and 2-furfuryl aldoxime of OxdYH3-3 was
screened by measuring UV absorbance. The absorbance of 3-E-pyridine aldoxime, 3-cyanopyridine,
2-furfuryl aldoxime, and 2-furonitrile were scanned from 200 to 300 nm to observe the difference
between aldoxime and nitrile as a time course. After the reaction supernatant was diluted with
a phosphate buffer (pH 7.0, 50 mM) from 10 to 100 times, the absorbance was determined with a
microplate spectrophotometer (Tecan).
3.11. Homology Modelling
The homology models of OxdYH3-3 WT and N266S were created by SWISS-MODEL and Modeller
using OxdRE which contains heme and 1-Z-butanal oxime as a template and following verification
by QMEAN server and ERRAT in ERRAT server [16,31–33]. The modelling that was created by
SWISS-MODEL showed high scores within verification; therefore, this model was used for further
study. The structure optimization of 2-E-furfuryl aldoxime was done by Avogadro [34]. Molecular
docking studies with OxdYH3-3 WT and N266S were performed by Autodock4 and visualized by
autodock tools and PyMOL [35]. The hydrogen bonds between ligands adjacent residues were analyzed
with LIGPLOT program [36]. Models that were chosen for the next step was subjected to an analysis of
residues network that used Ring 2.0 and Cytoscape [29,30] and a further analysis that used the UCSF
Chimera program [37].
4. Conclusions
In conclusion, the successful development of mutants of the recombinant aldoxime dehydratase
OxdYH3-3 in E.coli BL21(DE3) that were generated by directed evolution and its enhanced activity
toward 2-furfuryl aldoxime has been reported. Approximately 1000 mutant clones were constructed
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by random mutagenesis, and the primary screening was done by measuring absorbance at 270 nm,
which corresponded to E-2-furfuryl aldoxime. The prioritized mutant OxdYH3-3 N266S showed an
improved activity of up to six times higher than the wild type when utilizing a substrate concentration
of 50–100 mM of 2-furfuryl aldoxime, thus furnishing 2-furonitrile being a valuable nitrile product for
the chemical industry due to its use as intermediate in the field of fine chemicals and pharmaceuticals
or as potential sweetener, as well as due to its access from biorenewables. Interestingly, the mutation of
this improved biocatalyst OxdYH3-3 N266S is located at a remote site that is far away from the active
pocket. Among the next steps for future research work is the optimization of this biotransformation
towards a process running at high substrate loading, thus fulfilling requirements of an industrially
attractive application.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4344/10/4/362/s1,
Additional result of NMR and ESI-MS spectra, Figure S1: Alignment of translated polypeptide sequences of
OxdYH3-3 WT and mutants, Figure S2: Michaelis–Menten plot of OxdYH3-3 WT (A) and N266S (B) towards
2-furfuryl aldoxime. Figure S3: Diagram of interactions between OxdYH3-3 WT (A) and N266S (B) to E-2-furfuryl
aldoxime. The purple and yellow line showed ligand and non-ligand bond, respectively. The green dashed line
indicates a hydrogen bond and its length. Protein residues involving hydrophobic contacts were shown as a
red half circle with spikes, Figure S4: Residue interaction networks (RINs) of nonmutated residue Asn266 from
OxdYH3-3 WT ((A) and (B)) and mutated residue Asn266Ser from N266S ((C) and (D)). Pink nobs interact residues
with Asn266 and Asn266Ser, and yellow nobs are the residues directed connected to them. Asn266 in OxdYH3-3
WT interacts with Asp60, Thr82, Leu276, and Leu81 through a hydrogen bond, and Tyr278 through Van der Waals
interaction which forming interaction with Ser219 (A), and it was visualized as 3D structure (B). Ball structure
shows Ans266, and sticks are networking residues with Asn266 within 5 Å of ligand. The blue stick is E-2-furfuryl
aldoxime. On the other hand, Ans266Ser in OxdYH3-3 N266S shows only two hydrogen bond interactions with
Leu276 and Leu 274 and no other types of interactions (C), suggesting no interaction with residues in the binding
pocket (D).
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